CN116196359A - 一种治疗风湿跌打通脉中药酒及其制备方法 - Google Patents
一种治疗风湿跌打通脉中药酒及其制备方法 Download PDFInfo
- Publication number
- CN116196359A CN116196359A CN202310097850.7A CN202310097850A CN116196359A CN 116196359 A CN116196359 A CN 116196359A CN 202310097850 A CN202310097850 A CN 202310097850A CN 116196359 A CN116196359 A CN 116196359A
- Authority
- CN
- China
- Prior art keywords
- parts
- root
- chinese medicine
- traditional chinese
- medicine wine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 44
- 208000014674 injury Diseases 0.000 title claims abstract description 29
- 230000008736 traumatic injury Effects 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title abstract description 15
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 19
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 14
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 14
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 13
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 13
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 12
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 12
- 241000212322 Levisticum officinale Species 0.000 claims abstract description 12
- 239000001645 levisticum officinale Substances 0.000 claims abstract description 12
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 11
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 11
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 11
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 11
- 239000004863 Frankincense Substances 0.000 claims abstract description 11
- 241000405414 Rehmannia Species 0.000 claims abstract description 11
- 241000427159 Achyranthes Species 0.000 claims abstract description 10
- 241001254604 Angelica pubescens Species 0.000 claims abstract description 9
- 241000601164 Clematis orientalis Species 0.000 claims abstract description 9
- 241001180876 Saposhnikovia Species 0.000 claims abstract description 9
- 241000123589 Dipsacus Species 0.000 claims abstract description 8
- 230000036407 pain Effects 0.000 claims description 39
- 208000002193 Pain Diseases 0.000 claims description 38
- 230000008961 swelling Effects 0.000 claims description 17
- 238000002791 soaking Methods 0.000 claims description 13
- 208000006820 Arthralgia Diseases 0.000 claims description 10
- 241001038563 Pseudostellaria Species 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 4
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 4
- 241000903946 Clematidis Species 0.000 claims description 3
- 241000112528 Ligusticum striatum Species 0.000 claims description 3
- 244000197580 Poria cocos Species 0.000 claims description 3
- 235000008599 Poria cocos Nutrition 0.000 claims description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 3
- 235000011477 liquorice Nutrition 0.000 claims description 3
- 240000000031 Achyranthes bidentata Species 0.000 claims description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 2
- 230000000472 traumatic effect Effects 0.000 claims description 2
- 210000003462 vein Anatomy 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 241000125175 Angelica Species 0.000 claims 1
- 230000003203 everyday effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 description 27
- 206010042674 Swelling Diseases 0.000 description 16
- 210000000952 spleen Anatomy 0.000 description 14
- 241000699670 Mus sp. Species 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 206010039073 rheumatoid arthritis Diseases 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 10
- 210000002683 foot Anatomy 0.000 description 9
- 235000019640 taste Nutrition 0.000 description 9
- 229920001817 Agar Polymers 0.000 description 8
- 239000008272 agar Substances 0.000 description 8
- 210000002216 heart Anatomy 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 230000000699 topical effect Effects 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 208000005392 Spasm Diseases 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 230000002757 inflammatory effect Effects 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 238000012449 Kunming mouse Methods 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 208000000112 Myalgia Diseases 0.000 description 3
- 238000007605 air drying Methods 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 229960000905 indomethacin Drugs 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 208000015001 muscle soreness Diseases 0.000 description 3
- 230000003387 muscular Effects 0.000 description 3
- 239000011505 plaster Substances 0.000 description 3
- 235000019633 pungent taste Nutrition 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 2
- 206010006002 Bone pain Diseases 0.000 description 2
- 235000018062 Boswellia Nutrition 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 241001412225 Firmiana simplex Species 0.000 description 2
- 206010018691 Granuloma Diseases 0.000 description 2
- 208000012659 Joint disease Diseases 0.000 description 2
- 206010023232 Joint swelling Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000010040 Sprains and Strains Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 210000003423 ankle Anatomy 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000000548 hind-foot Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- 244000061520 Angelica archangelica Species 0.000 description 1
- 208000036487 Arthropathies Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000208229 Burseraceae Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 241001632410 Eleutherococcus senticosus Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022562 Intermittent claudication Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000016285 Movement disease Diseases 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 229920000175 Pistacia lentiscus Polymers 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 208000035999 Recurrence Diseases 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 206010040830 Skin discomfort Diseases 0.000 description 1
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 206010044546 Traumatic ulcer Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 208000024980 claudication Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Physiology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗风湿跌打通脉中药酒及其制备方法,属于中药酒制备技术领域。该治疗风湿跌打通脉中药酒由以下重量份的组分组成:防风8‑15份、桂枝8‑15份、陈皮8‑15份、白芷8‑15份、甘草8‑15份、川芎8‑15份、独活8‑15份、五加皮10‑20份、牛膝8‑15份、当归10‑20份、生地10‑20份、茯苓10‑20份、威灵仙10‑20份、太子参8‑15份、川断8‑15份、乳香8‑15份、没药8‑15份、山枝8‑15份、红花8‑15份、白酒800‑1000份,该中药酒在治疗跌打损伤的同时兼具治疗类风湿性关节炎功效。
Description
技术领域
本发明涉及中药酒制备技术领域,更具体的涉及一种治疗风湿跌打通脉中药酒及其制备方法。
背景技术
类风湿性关节炎(rheumatoid arthritis,RA)是人们生活中的常见疾病,是一种以关节病变为主的慢性自身免疫性疾病,其可引起关节肿痛、软骨破坏,关节畸形,甚至可导致残疾。RA发病主要由遗传、自身免疫和环境等因素共同作用。RA对人们健康生活的危害极大,但目前临床上仍无能根治类风湿关节炎的方法。现有正在应用中的治疗方案也各有弊端,例如口服一、二线抗RA药物非甾体抗炎药和糖皮质激素毒副作用较大;外用药膏药、药贴等只能暂时缓解疼痛,且容易产生皮肤不适感;理疗作为辅助治疗,需花较多时间,影响人们的正常工作和生活,以上方法均无法达到治愈的效果。
跌打损伤泛指人因跌、打、碰、磕等原因所致的软组织损伤,以红、肿、疼痛为主要表现。虽然类风湿性关节炎和跌打损伤的病因不同,但病灶处均有肿痛的症状,中医认为,痛者不通,若需治疗则先活血化瘀,打通经络。
目前临床上有许多治疗跌打损伤的中药制剂,但同时兼具治疗类风湿性关节炎功效,且可内服外用的制剂并不多,并且,检索发现,大部分仍以膏药、贴剂为主,制备工艺复杂,成本较高,效果未见理想。
发明内容
本发明提供了一种治疗风湿跌打通脉中药酒及其制备方法,以解决上述问题。
本发明的第一个目的是提供一种治疗风湿跌打通脉中药酒,由以下重量份的组分组成:防风8-15份、桂枝8-15份、陈皮8-15份、白芷8-15份、甘草8-15份、川芎8-15份、独活8-15份、五加皮10-20份、牛膝8-15份、当归10-20份、生地10-20份、茯苓10-20份、威灵仙10-20份、太子参8-15份、川断8-15份、乳香8-15份、没药8-15份、山枝8-15份、红花8-15份、白酒800-1000份。
优选的,所述白酒为35-45°白酒。
优选的,所述中药酒内服和/或外用。
优选的,内服时,每日服用15-20ml,内服7天为一个疗程,使用3至4个疗程。
优选的,外用时将药酒加热至25-30℃,涂搽于疼痛关节处,直至肿胀疼痛消除。
本发明提供了上述治疗风湿跌打通脉中药酒的制备方法,按照以下步骤进行制备:
步骤1、称取以下重量份的组分:防风8-15份、桂枝8-15份、陈皮8-15份、白芷8-15份、甘草8-15份、川芎8-15份、独活8-15份、五加皮10-20份、牛膝8-15份、当归10-20份、生地10-20份、茯苓10-20份、威灵仙10-20份、太子参8-15份、川断8-15份、乳香8-15份、没药8-15份、山枝8-15份、红花8-15份、白酒800-1000份;
步骤2、将防风、桂枝、陈皮、白芷、甘草、川芎、独活、五加皮、双奇、牛膝、当归、生地、茯苓、威灵仙、太子参、川断、乳香、没药、山枝、红花混合均匀后,加入白酒浸泡30-60分钟,然后文火煎煮30-35分钟,冷却后贮存一个月即可得到治疗风湿跌打通脉中药酒。
优选的,步骤2中,浸泡时间为30分钟。
优选的,步骤2中,文火煎煮时间为30分钟。
与现有技术相比,本发明具有以下有益效果:
(1)本发明中各药材的药理作用及功效:
防风:药用干燥根,味辛、甘,性微温。有祛风解表,胜湿止痛,止痉的功效。
桂枝:药用干燥嫩枝,味辛、甘,温,入肺、心、膀胱经,是主治里寒常用的温里药,具有补元阳、通血脉、暖脾胃之功效。
陈皮:为芸香科植物橘及其栽培变种的干燥成熟果皮,味苦、辛,性温。归肺、脾经。具有理气健康、燥湿化痰之功效。用于胸胁胀痛,疝气,乳核,食积腹痛。
白芷:药用干燥根,味辛,性温。归胃、大肠、肺经。具有散风除湿、通窍止痛、消肿止痛、消肿排脓之功效。用于感冒头痛,眉棱骨痛,鼻塞,鼻渊,牙痛,白带,疮疡肿痛。
甘草:药用干燥根及根茎,味甘,性平。归心、肺、脾、胃经。具有补脾益气、清热解毒、去痰止咳、缓急止痛、调和诸药之功效。用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。
川芎:药用干燥根、茎,味辛,性温。具有活血行气、祛风止痛之功效。用于月经不调,经闭,痛经,胸胁刺痛,跌扑肿痛,头痛,风湿痹痛。
独活:药用干燥根,味辛、苦,性微温。具有祛风除湿、通痹止痛之功效。用于风寒湿痹,腰膝疼痛,少阴伏风头痛。
五加皮:药用干燥根、皮,味辛、苦,性温。归肝、肾经。具有祛风湿、补肝肾、舒筋骨之功效。用于风湿痹痛,筋骨痿软,小儿行迟,体虚乏力,水肿,脚气。
牛膝:药用干燥根,味苦、酸、平,具有治疗肝肾不足之筋骨酸软,腰膝疼痛,经闭瘀血,风湿疼痛的功效。
当归:药用干燥根,味甘、辛、苦,性温。归肝、心、脾经。具有补血活血、调经止痛、润肠通便之功效。用于血虚萎黄,眩晕心悸,月经不调,闭经,痛经,虚寒腹痛,肠燥便秘,风湿痹痛,跌扑损伤,痈疽疮疡。
生地:药用干燥根,味甘、苦、寒,可用于治疗血热而致的出血,“血热”所致的皮肤病,糖尿病、风湿性和类风湿性关节炎。
茯苓:药用干燥菌核。性甘、平。入心、脾、胃、肺、肾经。用于治疗水肿、小便不利、痰饮,用于健脾化湿,治疗脾胃虚弱引起的消化不良,上腹满涨,食欲减少以及脾虚泄泻等。
威灵仙:药用干燥根状茎及根,味辛,温。具有祛风湿,通经络。用于风湿性关节炎,关节不利。
太子参:药用干燥根,味甘,微苦,微温。入心、脾、肺三经。具有补气益血、生津、补脾胃的功效。用于脾虚体倦,食欲不振,病后虚弱,气阴不足,自汗口渴,肺燥干咳。
川断:药用干燥根,味苦、辛、微温。用于跌打损伤,痈疽肿痛,腰膝无力,风湿痹痛,胎动不安及崩漏等症。
乳香:为橄榄科植物小乔木或乔木卡氏乳香树鲍达乳香树及野乳香树等干燥的树脂,味苦、辛、温。入心、肝、脾经。具有活血止痛,消肿生肌的功效。主治瘀血心腹诸痛,痹痛筋挛,痈疽肿痛,跌打损伤,疮疡溃烂。
没药:为橄榄科植物没药树,或爱伦堡没药(产地名哈迪树)干燥的树脂。味苦、辛、平。入肝经。活血散瘀镇痛,外用有收敛和消炎作用。
山枝:为海桐花科植物光叶海桐的根或根皮,性甘、苦、辛,具有补肺肾、祛风湿、活血通络等功效。
红花:药用花,味辛,性温。归心,肝经。具有活血通经、散瘀止痛的功效。用于必经,通经,恶露不行,癥瘕痞块,跌扑损伤,疮疡肿痛。
(2)本发明的中药酒即可内服也可外用,具有免疫调节、消肿止痛、活血通络的功效,适用于风湿骨痛、跌打肿痛、肌肉酸痛等症,具有制备方法简单,成本低,见效快,疗程短、效果明显,无刺激等特点;
(3)本发明制备的中药酒在治疗跌打损伤的同时兼具治疗类风湿性关节炎功效。
具体实施方式
下面对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。本发明各实施例中所述实验方法,如无特殊说明,均为常规方法。
实施例1
用于类风湿性关节炎。本实施例原料药重量比例:防风10份、桂枝10份、陈皮10份、白芷10份、甘草10份、川芎10份、独活10份、五加皮15份、牛膝10份、当归15份、生地15份、茯苓15份、威灵仙15份、太子参10份、川断10份、乳香10份、没药10份、山枝10份、红花10份,将以上原料洗净,晾干,按上述比例混合后,加入800份35°白酒内浸泡30分钟,然后文火同煮30分钟,之后放冷密闭泡制一个月,取汁即制成药酒。
内服外涂,内服一次15ml,每日3次,一个疗程为7天,常规治疗3-4个疗程。内服3-4个疗程可使年复发率大大减小或无复发,根据病例观察疗效确定的疗程时间,药酒不能长时间服用,因为长时间饮酒类,对肝脏功能有影响,所以采用3-4个疗程。
外用时将药酒加热至30℃左右,涂搽于疼痛关节处,搽之患处微微发热变红即可,用药时间由疼痛程度确定,外用至肿胀疼痛消除即可。
实施例2
用于肌肉酸痛。防风12份、桂枝12份、陈皮12份、白芷12份、甘草12份、川芎12份、独活12份、五加皮15份、牛膝12份、当归15份、生地15份、茯苓15份、威灵仙15份、太子参12份、川断12份、乳香12份、没药12份、山枝12份、红花12份。将以上原料洗净,晾干,按上述比例混合后,加入1000份40°白酒内浸泡40分钟,然后文火同煮30分钟,之后放冷密闭泡制一个月,取汁即制成药酒。
内服外涂,内服一次20ml,每日3次,一个疗程为7天,常规治疗3-4个疗程。
外用时将药酒加热至25℃左右,涂搽于疼痛关节处,搽之患处微微发热变红即可,用药时间由疼痛程度确定。
实施例3
用于跌打损伤。本实施例原料药重量比例:防风15份、桂枝15份、陈皮15份、白芷15份、甘草15份、川芎15份、独活15份、五加皮20份、牛膝15份、当归20份、生地20份、茯苓20份、威灵仙20份、太子参15份、川断15份、乳香15份、没药15份、山枝15份、红花15份。将以上原料洗净,晾干,按上述比例混合后,加入1000份45°白酒内浸泡60分钟,然后文火同煮35分钟,之后放冷密闭泡制2个月,取汁即制成药酒。
内服外涂,内服一次15ml,每日3次,一个疗程为7天,常规治疗3-4个疗程。
外用时将药酒加热至30℃左右,涂搽于疼痛关节处,搽之患处微微发热变红即可,用药时间由疼痛程度确定。
实施例4
本实施例原料药重量比例:防风8份、桂枝8份、陈皮8份、白芷8份、甘草8份、川芎8份、独活8份、五加皮10份、牛膝8份、当归10份、生地10份、茯苓10份、威灵仙10份、太子参8份、川断8份、乳香8份、没药8份、山枝8份、红花8份。将以上原料洗净,晾干,按上述比例混合后,加入900份45°白酒内浸泡30分钟,然后文火同煮35分钟,之后放冷密闭泡制1.5个月,取汁即制成药酒。
内服外涂,内服一次15ml,每日3次,一个疗程为7天,常规治疗3-4个疗程。
外用时将药酒加热至27℃左右,涂搽于疼痛关节处,搽之患处微微发热变红即可,用药时间由疼痛程度确定。
本发明制备实施例1的治疗风湿跌打通脉中药酒的药理毒理学试验:
(1)抗炎作用
对琼脂致小鼠肉芽肿的影响:昆明小鼠雄性50只,随机分为5组,每组10只,将中药酒分为高、低两个剂量(相当于原药酒3、6ml/g),消炎痛10mg/kg为阳性对照组,阴性对照组和模型对照组均给予生理盐水,除了阴性对照组,其他组小鼠均在背部皮下注射2%琼脂0.3ml/只,并与第二天开始连续灌胃用药7天,第8天将小鼠脱颈椎处死,剥离琼脂肉芽块,并称湿重,并计算肿胀抑制率,抑制率=(模型对照组琼脂肉芽重量-给药组琼脂重量)/模型对照组琼脂肉芽重量×100%。结果如表1显示,中药酒高剂量可显著减轻小鼠背部琼脂肉芽的重量,提示中药酒高剂量对慢性炎症有抑制作用。
注:与模型组比较,*P<0.05,**P<0.01;与阳性对照组比较,#P<0.05,##P<0.01。
对小鼠炎症渗出物中PGE2含量的影响:昆明小鼠雄性40只,随机分为4组,每组10只,将中药酒分为高、低两个剂量(相当于原药酒3、6ml/g),消炎痛10mg/kg为阳性对照组,生理盐水为阴性对照组,连续7天,末次给药后30min,除阴性对照组外,在其他组小鼠的右后足皮下注射1%角叉菜胶0.03ml,4h后剪下所有动物炎足称其质量,充分剪碎,于2ml生理盐水中浸泡1h后离心,取上清液0.25ml,加入0.5mol/L的氢氧化钾溶液2ml,50℃水浴20min加5ml甲醇稀释,于278nm处测吸光度,以吸光度与足重比值作为PGE2(前列腺素E2)含量,结果如表2显示,该中药酒高、低剂量(相当于原药酒3、6ml/g)均能显著拮抗角叉菜胶致小鼠炎症炎性组织中PGE2的增高,提示其抗炎机制可能与抑制PGE2合成或释放有关。
注:与模型组比较,*P<0.05,**P<0.01;与阳性对照组比较,#P<0.05,##P<0.01。
(2)镇痛作用
对福尔马林致小鼠疼痛的影响:昆明小鼠雄性40只,随机分为4组,每组10只,将中药酒分为高、低两个剂量(相当于原药酒3、6ml/g),消炎痛10mg/kg为阳性对照组,生理盐水为阴性对照组,连续5天。末次给药后1h,每只小鼠右后足趾皮下注射2%的福尔马林20μl后,立即置于直径为20cm玻璃缸内,在注射后0-5min内记录累积舔右后足时间,并进行评分,评分标准:舔、咬或抖足3分,提足2分,跛行、不动时足撑地1分,走动自如0分,并进行组间比较。结果如表3显示,中药酒高、低剂量组均能减少小鼠累计舔足时间,提示该中药酒对直接刺激疼痛神经末梢引起的疼痛具有镇痛作用。
注:与模型组比较,*P<0.05,**P<0.01;与阳性对照组比较,#P<0.05,##P<0.01。
本发明选取3例典型病例记录如下:
病例1:类风湿性关节炎。陈明凤,女,45岁,患类风湿性关节炎病20年,遇天气潮湿寒冷,单个至多个关节受累,各受累关节会出现晨僵,肿胀,疼痛的症状,个人活动受限,行走困难。关节X线见关节肿胀,关节间隙增宽及关节周围软组织肿胀,骨质疏松,治疗多年不愈。患者服用本发明实施例1制备的中药酒,每日一次饮用15ml,每日3次,连续服用3个疗程,同时取药酒加热至25-35℃,涂搽于疼痛关节处,至皮肤微微发红、发热,持续涂搽5天后疼痛消除,让后停止涂搽。X线检测关节软组织肿胀消失,骨质疏松症状改善,晨僵及关节疼痛的症状消失,经过1年观察,患者类风湿性关节炎无复发,走路活动自如。
病例2:颈背部肌肉酸痛。郑常远,男,30岁,职业白领,久坐看电脑办公,发现颈背部肌肉酸痛,身子无力疲惫。取本发明实施例2制备的中药酒适量加热至25-35℃,涂搽于肌肉酸痛处,涂搽至皮肤微微发红,发热,持续涂搽两天,酸痛症状消失,身体恢复力气,且无复发。
病例3:扭伤。李成,男,24岁,学生,打篮球时不慎扭伤左脚,脚踝处肿胀,发红,左脚无法行走。取本发明实施例3制备的中药酒适量加热至25-35℃,涂搽于肌肉酸痛处,涂搽至皮肤微微发红,发热,持续涂搽四天,左脚脚踝处肿胀、疼痛消失,可自如行走,且无复发。
尽管已描述了本发明的优选实施例,但本领域内的技术人员一旦得知了基本创造性概念,则可对这些实施例作出另外的变更和修改。所以,所附权利要求意欲解释为包括优选实施例以及落入本发明范围的所有变更和修改。
显然,本领域的技术人员可以对本发明进行各种改动和变型而不脱离本发明的精神和范围。这样,倘若本发明的这些修改和变型属于本发明权利要求及其等同技术的范围之内,则本发明也意图包含这些改动和变型在内。
Claims (8)
1.一种治疗风湿跌打通脉中药酒,其特征在于,由以下重量份的组分组成:防风8-15份、桂枝8-15份、陈皮8-15份、白芷8-15份、甘草8-15份、川芎8-15份、独活8-15份、五加皮10-20份、牛膝8-15份、当归10-20份、生地10-20份、茯苓10-20份、威灵仙10-20份、太子参8-15份、川断8-15份、乳香8-15份、没药8-15份、山枝8-15份、红花8-15份、白酒800-1000份。
2.根据权利要求1所述的一种治疗风湿跌打通脉中药酒,其特征在于,所述白酒为35-45°白酒。
3.根据权利要求1所述的一种治疗风湿跌打通脉中药酒,其特征在于,所述中药酒内服和/或外用。
4.根据权利要求3所述的一种治疗风湿跌打通脉中药酒,其特征在于,内服时,每日服用15-20ml,内服7天为一个疗程,使用3至4个疗程。
5.根据权利要求3所述的一种治疗风湿跌打通脉中药酒,其特征在于,外用时将药酒加热至25-30℃,涂搽于疼痛关节处,直至肿胀疼痛消除。
6.一种权利要求1所述的治疗风湿跌打通脉中药酒的制备方法,其特征在于,按照以下步骤进行制备:
步骤1、称取以下重量份的组分:防风8-15份、桂枝8-15份、陈皮8-15份、白芷8-15份、甘草8-15份、川芎8-15份、独活8-15份、五加皮10-20份、牛膝8-15份、当归10-20份、生地10-20份、茯苓10-20份、威灵仙10-20份、太子参8-15份、川断8-15份、乳香8-15份、没药8-15份、山枝8-15份、红花8-15份、白酒800-1000份;
步骤2、将防风、桂枝、陈皮、白芷、甘草、川芎、独活、五加皮、双奇、牛膝、当归、生地、茯苓、威灵仙、太子参、川断、乳香、没药、山枝、红花混合均匀后,加入白酒浸泡30-60分钟,然后煎煮30-35分钟,冷却后贮存一个月即可得到治疗风湿跌打通脉中药酒。
7.根据权利要求6所述的一种治疗风湿跌打通脉中药酒的制备方法,其特征在于,步骤2中,浸泡时间为30分钟。
8.根据权利要求6所述的一种治疗风湿跌打通脉中药酒的制备方法,其特征在于,步骤2中,煎煮时间为30分钟。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310097850.7A CN116196359A (zh) | 2023-02-10 | 2023-02-10 | 一种治疗风湿跌打通脉中药酒及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310097850.7A CN116196359A (zh) | 2023-02-10 | 2023-02-10 | 一种治疗风湿跌打通脉中药酒及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116196359A true CN116196359A (zh) | 2023-06-02 |
Family
ID=86518657
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310097850.7A Pending CN116196359A (zh) | 2023-02-10 | 2023-02-10 | 一种治疗风湿跌打通脉中药酒及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116196359A (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101513469A (zh) * | 2008-02-22 | 2009-08-26 | 北京天科仁祥医药科技有限公司 | 一种抗风湿性关节炎的中药组合物及其制备方法 |
-
2023
- 2023-02-10 CN CN202310097850.7A patent/CN116196359A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101513469A (zh) * | 2008-02-22 | 2009-08-26 | 北京天科仁祥医药科技有限公司 | 一种抗风湿性关节炎的中药组合物及其制备方法 |
Non-Patent Citations (1)
Title |
---|
马世华;: "中西医结合治疗类风湿关节炎60例疗效观察", 中国医药指南, vol. 10, no. 32, pages 619 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106421663A (zh) | 一种治疗风湿骨病的药物组合物及其制备方法 | |
CN104815318A (zh) | 一种治疗痛风的中药制剂 | |
CN104383445A (zh) | 一种跌打损伤止痛剂 | |
CN102872301A (zh) | 抗风湿药酒及其使用方法 | |
CN102755622A (zh) | 一种治疗类风湿的药物 | |
CN103735647A (zh) | 一种治疗类风湿性关节炎的药酒 | |
CN106491887A (zh) | 一种颈腰康康复贴及其制备方法 | |
CN105641330A (zh) | 一种补肾壮阳的中药组合物 | |
CN116196359A (zh) | 一种治疗风湿跌打通脉中药酒及其制备方法 | |
CN105641060A (zh) | 一种强身壮阳的药物组合物 | |
CN105311210A (zh) | 治疗风湿骨病的药物组合物 | |
CN104825768A (zh) | 一种治疗淋巴结核的中药口服液及制备方法 | |
CN104524080A (zh) | 主治跌打损伤中药剂及制备方法 | |
CN103961555A (zh) | 一种治疗周围神经损伤的中药制剂及制备方法 | |
CN103961490A (zh) | 一种治疗风寒湿痹的复方药物及其制备方法 | |
CN111265644A (zh) | 一种活骨止痛贴膏及其制备方法 | |
CN107412512A (zh) | 一种治疗下肢静脉曲张的药物组合物 | |
CN106421514A (zh) | 一种用于治疗关节痛的中药 | |
CN106421255A (zh) | 一种外用中草药组合物及其应用 | |
CN105663383A (zh) | 一种强身壮阳的中药组合物 | |
CN105560610A (zh) | 一种治疗骨折的中药及制备方法 | |
CN105664143A (zh) | 一种强身壮阳的药物组合物及其制备方法 | |
CN105412484A (zh) | 一种治疗关节疼痛的药物及制备方法 | |
CN104161935A (zh) | 治疗风湿、类风湿的药物 | |
CN116920064A (zh) | 一种治疗风湿骨病的中药配方及其加工方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |